Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative vs Postoperative Thymoglobulin in Lung Transplantation
NCT00592306Phase 3Withdrawn
- Sponsor
- University of California, Los Angeles
- Start
- Jan 2006
- Primary completion
- Sep 2009
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of antithymocyte globulin in lung transplantation, sponsored by University of California, Los Angeles. Primary endpoint: Primary Graft Dysfunction at 72 hours. Planned start Jan 2006; status: withdrawn.
02
Drugs
antithymocyte globulin
03
Conditions
lung transplantation
Beyond the preview
Go deeper on NCT00592306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00592306.